DOCSLIB.ORG

IMFAR 2007 Program Booklet & Abstracts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
IMFAR 2007 Program Booklet & Abstracts IMFAR INTERNATIONAL MEETING FOR AUTISM RESEARCH 6th Annual Meeting IMFAR May 3 - 5, 2007 Seattle, Washington IIMFAR IMFAR REGISTRATION WILL BE LOCATED IN THE GRAND BALLROOM FOYER. REGISTRATION OPEN WEDNESDAY 5-8 PM AND STARTING 7 AM THURSDAY IMFAR 2007 THURSDAY, MAY 3 FRIDAY, MAY 4 SATURDAY, MAY 5 7:30-8:15 Breakfast Grand Ballroom Foyer Breakfast Grand Ballroom Foyer Breakfast Grand Ballroom Foyer 8:00 Opening Comments: Geraldine Dawson 8:10 ADVOCACY GROUP INTRODUCTION ADVOCACY GROUP INTRODUCTION ADVOCACY GROUP INTRODUCTION Autism Society of America: Cathy Pratt Autism Speaks: Peter Bell and Mark Roithmayr Cure Autism Now: Jon Shestack and Portia Iversen 8:30-9:30 Introduction: Geraldine Dawson Introduction: Elizabeth Aylward Introduction: Susan Bookheimer Keynote Address: Anthony Bailey Keynote Address: Patricia Kuhl Keynote Address: Daniel Geschwind The Neuroscience of autism: Tackling Language learning and the 'Social Brain': Implications Tackling genetic heterogeneity in autism: complexity for children with autism An array of approaches Grand Ballroom ABC Grand Ballroom ABC Grand Ballroom ABC 9:30-9:50 Coffee Break Grand Ballroom Foyer Coffee Break Grand Ballroom Foyer Coffee Break Grand Ballroom Foyer 9:50- Invited Educational Symposia llroom D Invited Educational Symposia Invited Educational Symposia 11:45 Infants with autism: Can animal models lead Medical aspects of Genetic approaches to New approaches Adolescent and A world view of New approaches to to treatments for social Autism Spectrum autism: Complex methods for neuroimaging adult interventions autism early detection & deficits in ASD? Disorders for a complex disorder in autism. Declan and outcomes epidemiology treatment Manny Dicicco-Bloom Margaret Bauman Gerard Schellenberg, John Murphy, Tom Fred Frankel, Marshalyn Geraldine Dawson Sponsor: Autism Speaks Constantino Conturo Cathy Lord Yeargin-Allsopp Sponsor: Autism Speaks A C A C A B C PosterGrand 3 Ba PosterGrand 5 Ballroom D 11:45- PosterGrand 1 Ballroom D Lunch Grand Ballroom Foyer Lunch Grand Ballroom Foyer Lunch Grand Ballroom Foyer 1:00 12:15-12:45 Special Event: Videotaped greeting by 12-12:45 Special Event: Award-winning documentary film, Dr. Kalam, President of India Grand Ballroom ABC “Autism Every Day” Grand Ballroom ABC Poster session 1 Grand Ballroom D Poster session 3 Grand Ballroom D Poster session 5 Grand Ballroom D 1:00-2:20 Oral Sessions 1,2,3 Oral Sessions 7,8,9 1:00-1:45: Dissertation, Young Investigator and Lifetime Achievement Award Awards. Presenter: Sally Rogers; Brain Cognition Treatment and Functional Autism Autism phenotypes Keynote Address: Uta Frith “Autism and the Absent Self” structure Dermot outcome Lonnie imaging epidemiology Annette Estes Introduction: Geraldine Dawson Joe Piven Bowler Zwaigenbaum Nancy Rita Cantor Grand Ballroom ABC Minshew A B C A B C 1:45-2:10 Coffee Break Grand Ballroom Foyer 2:20-2:50 Coffee Break Grand Ballroom Foyer Coffee Break Grand Ballroom Foyer 2:10- 3:30 Oral Sessions 13,14,15 2:50-4:10 Oral Sessions 4,5,6 Oral Sessions 10,11,12 Emotions & Sensory motor Education, community- Neurophysiology Diagnosis & Neuropathology Innovative Models of social Inter- systems and based services & allroom D Genetics and neuro- screening immunology technologies for autism actions. repetitive behavior treatment Jim Sutcliffe psychology Wendy and toxicology diagnosis and Mirella Ami Klin Stewart Mostofsky David Mandell Sara Webb Stone Gene Blatt treatment. Dapretto A B C Gregory Abowd 3:30-4:30 Poster Session 6 Grand Ballroom D A B C A B C 4:30 IMFAR 2008 Announcements: Tony Charman Meeting Close 4:30-5:15 Special Presentation: Allan Jones, Allen Special Presentation: Thomas Insel, Director, NIMH Poster 6 Grand Ballroom D Institute for Brain Science: "The Mouse “The Combating Autism Act” PosterGrand 4 Ballroom D PosterGrand 2 B Transcriptome in 3D: The Allen Brain Atlas Introduction: Susan Bookheimer Grand Ballroom ABC Project" Introduction: Geraldine Dawson Grand Ballroom ABC Grand Ballroom ABC 5:15-6:15 Poster session 2 Poster Session 4 6:45-7:45 A: Grand Ballroom A Grand Ballroom D Grand Ballroom D Business Meeting B: Grand Ballroom B Grand Ballroom ABC C: Grand Ballroom C 5:15-6:45 Reception - Sponsored by INSAR Reception - Sponsored by Autism Speaks Grand Ballroom Foyer Grand Ballroom Foyer Table of Contents IMFAR Welcome...................................................................................................................2 Retiring President Welcome ..................................................................................................3 Announcement for Parents .....................................................................................................4 Acknowledgements ................................................................................................................5 Program Agenda ....................................................................................................................7 Poster Session at a Glance .....................................................................................................18 Abstracts ................................................................................................................................19 Thursday May 3 ..................................................................19-82 Symposia ..................................... 19-20 Oral Sessions 1-3 ........................ 22-30 Poster Session #1 ........................ 32-55 Poster Session #2 ........................ 56-73 Oral Sessions 4-6 ........................ 74-82 Friday May 4 .......................................................................83-157 Symposia ..................................... 83-84 Poster Session #3 ...................... 86-112 Oral Sessions 7-9 .................... 113-121 Poster Session #4 .................... 123-148 Oral Sessions 10-12 ................ 149-157 Saturday May 5 ...................................................................159-217 Symposia ................................. 159-161 Poster Session #5 .................... 163-181 Oral Sessions 13-15 ................ 182-192 Poster Session #6 .................... 194-217 Author Index ..........................................................................................................................218 1 IMFAR Welcome Welcome to the Sixth Annual International Meeting for Autism Research! It is a pleasure to welcome you to Seattle for the 6th annual International Meeting for Autism Research. IMFAR is rapidly becoming the leading meeting for autism research worldwide. Both the number and quality of abstract submissions are strong, reflecting the outstanding work that is being conducted in the field of autism. As new funding and technologies infuse the field, we are beginning to witness exciting new findings which are bringing new perspectives and hope to the field of autism, and more importantly, to individuals with autism and their families. You will notice this year a strong emphasis on international participation with speakers and participants coming from Africa, Australia, Canada, Europe, Hong Kong, India, Israel, Japan, Singapore, Taiwan, Turkey, Venezuela, and the United States. A symposium featuring new findings on international epidemiology of autism will highlight the efforts being made to track prevalence and understand service delivery systems for persons with autism worldwide. We congratulate our first keynote speaker, Anthony Bailey, for being chosen as the new editor of the first journal sponsored by IMFAR, a historic moment in the society‟s history. Other invited symposia and key note speakers will describe recent findings in the areas of genetics and brain models of autism; these presentations will demonstrate how neuroscience and genetic research can translate into new approaches to early recognition and treatment of autism. Three additional invited symposia will describe novel directions in clinical practice. Two of these focus on different ends of the age spectrum – one on infants and the other on adolescents and adults. The third symposium will illustrate how medical conditions impact individuals with autism, and discuss how to detect and treat such medical conditions, with a goal of improving the quality of lives of individuals with autism and their families. In addition to these exciting invited presentations, numerous posters and oral presentations will be offered. Toward the end of the first two days, we have special presentations, one by Thomas Insel, Director, National Institutes of Mental Health, and the second by Allan Jones, Chief Scientific Officer, Allen Institute for Brain Sciences. Following each of these talks, we invite you to participate in a reception that will offer an opportunity to renew relationships and build new ones. Last, but not least, the ceremony announcing the Dissertation Award, Young Investigator Award, and Lifetime Achievement Award will be held on Saturday afternoon. Please come congratulate Uta Frith on her amazing lifetime contributions to the field. We wish to thank the many contributors who made IMFAR 2007 possible. We would like to express our gratitude to the INSAR Board and the Scientific Program Committee for their hard work. We especially wish to thank Sally Rogers for serving as President of INSAR this past year. IMFAR would not have been possible without the financial support from the Autism Society of America, Autism Speaks/Cure Autism Now, and NICHD, NIDCD, NINDS, and NIMH. Special thanks are extended to Teresa Brown
Load more

Recommended publications
  • Neural Signatures of Autism
    Neural signatures of autism Martha D. Kaisera, Caitlin M. Hudaca, Sarah Shultza,b, Su Mei Leea,b, Celeste Cheunga, Allison M. Berkena, Ben Deena, Naomi B. Pitskela, Daniel R. Sugruea, Avery C. Voosa, Celine A. Saulniera, Pamela Ventolaa, Julie M. Wolfa, Ami Klina, Brent C. Vander Wyka, and Kevin A. Pelphreya,b,1 aYale Child Study Center, Yale School of Medicine, New Haven, CT 06520, and bDepartment of Psychology, Yale University, New Haven, CT 06520 Edited by Dale Purves, Duke University Medical Center, Durham, NC, and approved October 13, 2010 (received for review July 19, 2010) Functional magnetic resonance imaging of brain responses to bi- well illustrated by the discovery that point-light displays (i.e., vid- ological motion in children with autism spectrum disorder (ASD), eos created by placing lights on the major joints of a person and unaffected siblings (US) of children with ASD, and typically devel- filming them moving in the dark), although relatively impov- oping (TD) children has revealed three types of neural signatures: (i) erished stimuli, contain sufficient information to identify the kind state activity, related to the state of having ASD that characterizes of motion being produced (e.g., walking, dancing, reaching), as the nature of disruption in brain circuitry; (ii) trait activity, reflecting well as the identity of the agent (8). Visual sensitivity to biological shared areas of dysfunction in US and children with ASD, thereby motion is an evolutionarily well-conserved and ontogenetically providing a promising neuroendophenotype to facilitate efforts to early-emerging mechanism that is fundamental to adaptive social bridge genomic complexity and disorder heterogeneity; and (iii) engagement (9); for example, newly hatched chicks recognize bi- compensatory activity, unique to US, suggesting a neural system– ological motion in point-light displays (10), and 2-d-old human level mechanism by which US might compensate for an increased infants preferentially attend to biological motion in point-light genetic risk for developing ASD.
    [Show full text]
  • House Bill 1306 Industry, Business and Labor January 19, 2021, 2:45
    House Bill 1306 Industry, Business and Labor January 19, 2021, 2:45 p.m. Good Morning Chairman Weisz and members of the House Human Services Committee. My name is Molly Howell and I am the Immunization Director of for the North Dakota Department of Health. I do not have testimony for HB1306 but want to let you know I am available virtually to answer questions, if needed. Additionally, attached is a list of studies that have been previously published regarding vaccines, autism and SIDS. Thank You. 1 Vaccine-Related Science: Autism and SIDS No Causal Association Found Autism Literature Reviews: Autism and Vaccines 1. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study PDF available here Annals of Internal Medicine March 2019 The study strongly supports that MMR vaccination does not increase the risk for autism, does not trigger autism in susceptible children, and is not associated with clustering of autism cases after vaccination. It adds to previous studies through significant additional statistical power and by addressing hypotheses of susceptible subgroups and clustering of cases. 2. Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism http://jama.jamanetwork.com/article.aspx?articleid=2275444 The Journal of the American Medical Association April 2015 In this large sample of privately insured children with older siblings, receipt of the MMR vaccine was not associated with increased risk of ASD, regardless of whether older siblings had ASD. These findings indicate no harmful association between MMR vaccine receipt and ASD even among children already at higher risk for ASD.
    [Show full text]
  • Autism Practice Parameters
    American Academy of Child and Adolescent Psychiatry AACAP is pleased to offer Practice Parameters as soon as they are approved by the AACAP Council, but prior to their publication in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP). This article may be revised during the JAACAP copyediting, author query, and proof reading processes. Any final changes in the document will be made at the time of print publication and will be reflected in the final electronic version of the Practice Parameter. AACAP and JAACAP, and its respective employees, are not responsible or liable for the use of any such inaccurate or misleading data, opinion, or information contained in this iteration of this Practice Parameter. PRACTICE PARAMETER FOR THE ASSESSMENT AND TREATMENT OF CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER ABSTRACT Autism spectrum disorder (ASD) is characterized by patterns of delay and deviance in the development of social, communicative, and cognitive skills which arise in the first years of life. Although frequently associated with intellectual disability, this condition is distinctive in terms of its course, impact, and treatment. ASD has a wide range of syndrome expression and its management presents particular challenges for clinicians. Individuals with an ASD can present for clinical care at any point in development. The multiple developmental and behavioral problems associated with this condition necessitate multidisciplinary care, coordination of services, and advocacy for individuals and their families. Early, sustained intervention and the use of multiple treatment modalities are indicated. Key Words: autism, practice parameters, guidelines, developmental disorders, pervasive developmental disorders. ATTRIBUTION This parameter was developed by Fred Volkmar, M.D., Matthew Siegel, M.D., Marc Woodbury-Smith, M.D., Bryan King, M.D., James McCracken, M.D., Matthew State, M.D., Ph.D.
    [Show full text]
  • Gesnerus 2020-2.Indb
    Gesnerus 77/2 (2020) 279–311, DOI: 10.24894/Gesn-de.2020.77012 Vom «autistischen Psychopathen» zum Autismusspektrum. Verhaltensdiagnostik und Persönlichkeitsbehauptung in der Geschichte des Autismus Rüdiger Graf Abstract Der Aufsatz untersucht das Verhältnis von Persönlichkeit und Verhalten in der Defi nition und Diagnostik des Autismus von Kanner und Asperger in den 1940er Jahren bis in die neueren Ausgaben des DSM und ICD. Dazu unter- scheidet er drei verschiedene epistemische Zugänge zum Autismus: ein exter- nes Wissen der dritten Person, das über Verhaltensbeobachtungen, Testver- fahren und Elterninterviews gewonnen wird; ein stärker praktisches Wissen der zweiten Person, das in der andauernden, alltäglichen Interaktion bei El- tern und Betreuer*innen entsteht, und schließlich das introspektive Wissen der ersten Person, d.h. der Autist*innen selbst. Dabei resultiert die Kerndif- ferenz in der Behandlung des Autismus daraus, ob man meint, die Persönlich- keit eines Menschen allein über die Beobachtung von Verhaltensweisen er- schließen zu können oder ob es sich um eine vorgängige Struktur handelt, die introspektiv zugänglich ist, Verhalten prägt und ihm Sinn verleihen kann. Die Entscheidung hierüber führt zu grundlegend anderen Positionierungen zu verhaltenstherapeutischen Ansätzen, wie insbesondere zu Ole Ivar Lovaas’ Applied Behavior Analysis. Autismus; Psychiatriegeschichte; Wissensgeschichte; Verhaltenstherapie; Neurodiversität PD Dr. Rüdiger Graf, Leibniz-Zentrum für Zeithistorische Forschung Potsdam, Am Neuen Markt 1, 14467 Potsdam, [email protected]. Gesnerus 77 (2020) 279 Downloaded from Brill.com09/27/2021 01:45:02AM via free access «Autistic Psychopaths» and the Autism Spectrum. Diagnosing Behavior and Claiming Personhood in the History of Autism The article examines how understandings of personality and behavior have interacted in the defi nition and diagnostics of autism from Kanner and As- perger in the 1940s to the latest editions of DSM and ICD.
    [Show full text]
  • Gruson-Wood Julia F 2018 Phd.Pdf (1.393Mb)
    ‘I’M A JUGGLING ROBOT:’ AN ETHNOGRAPHY OF THE ORGANIZATION AND CULTURE OF AUTISM-BASED APPLIED BEHAVIOUR THERAPIES IN ONTARIO, CANADA JULIA GRUSON-WOOD A DISSERTATION SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGAM IN SCIENCE AND TECHNOLOGY STUDIES YORK UNIVERSITY, ONTARIO AUGUST 2018 © Julia F Gruson-Wood 2018 ABSTRACT This dissertation is an ethnographic study of the culture, social organization, and everyday practices of providers and recipients of autism-based applied behavior therapies in Ontario, Canada. Autism-based applied behavior therapies are highly controversial evidence-based autism interventions that have become the standard of care, and the only guaranteed-funded services, for autistic people in this province. These therapies are provided by teachers in public autism classrooms, by parents in the home, and by personal support workers in group homes with autistic residents. The lives of many autistic people in this province, whether at school, in the home, or the community, are structured through completing behaviour therapy activities. The growing voices that resist and proliferate applied behaviour therapies, highlight the importance of critical scholarly attention to these therapies. This dissertation is situated within the fields of science studies, medical anthropology, and critical autism studies, and focuses on the experiences and practices of providers. Learning about what providers do, and how they make sense of what they do, helps to understand the professional culture in which they work, and the complex forces of power that govern both their activities and the everyday lives of autistic people in this province.
    [Show full text]
  • Interagency Autism Coordinating Committee
    1 INTERAGENCY AUTISM COORDINATING COMMITTEE FULL COMMITTEE MEETING THURSDAY, July 22, 2021 The full Interagency Autism Coordinating Committee (IACC) convened virtually, at 2:00 p.m., Joshua Gordon, M.D., Ph.D., Chair, presiding. PRESENT: JOSHUA GORDON, M.D., Ph.D., Chair, IACC, Director, National Institute of Mental Health, (NIMH) SUSAN DANIELS, Ph.D., Executive Secretary, IACC, Office of Autism Research Coordination (OARC), NIMH COURTNEY FERRELL AKLIN, Ph.D., National Institutes of Health (NIH)(representing Francis Collins, M.D., Ph.D.) MARIA MERCEDES AVILA, Ph.D., M.S.W., M.Ed. University of Vermont SKYE BASS, L.C.S.W., Indian Health Service (IHS) DIANA BIANCHI, M.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) SAMANTHA CRANE, J.D., Autistic Self Advocacy Network 2 PRESENT: (continued) AISHA DICKERSON, Ph.D., Johns Hopkins University TIFFANY FARCHIONE, M.D., U.S. Food and Drug Administration (FDA) MARIA FRYER, M.S., U.S. Department of Justice (DOJ) DAYANA GARCIA, M.Ed., Administration for Children and Families (ACF) DENA GASSNER, M.S.W., Adelphi University MORÉNIKE GIWA ONAIWU, M.A., Rice University ALYCIA HALLADAY, Ph.D., Autism Science Foundation CRAIG JOHNSON, B.A. Champions Foundation JENNIFER JOHNSON, Ed.D., Administration for Community Living (ACL) CINDY LAWLER, Ph.D., National Institute of Environmental Health Sciences (NIEHS) (representing Rick Woychik, Ph.D.) ALISON MARVIN, Ph.D., Social Security Administration (SSA) LINDSEY NEBEKER,B.A., Freelance Presenter/Trainer SCOTT PATTERSON, Ph.D., U.S. Department of Veterans Affairs (VA)(representing Matthew Miller, Ph.D., M.P.H.) VALERIE PARADIZ, Ph.D., Autism Speaks 3 PRESENT (continued) GEORGINA PEACOCK, M.D., M.P.H., F.A.A.P., Centers for Disease Control and Prevention (CDC) JENNY MAI PHAN, Ph.D., University of Wisconsin-Madison JOSEPH PIVEN, M.D., University of North Carolina-Chapel Hill JALYNN PRINCE, B.F.A., Madison House Autism Foundation LAUREN RAMOS, M.P.H., Health Resources and Services Administration (HRSA) SCOTT MICHAEL ROBERTSON, Ph.D., U.S.
    [Show full text]
  • Why We Oppose Autism Speaks
    Why We Oppose Autism Speaks Autism Speaks, despite its name, does not speak for autistic people. When polled, 98% of autistic adults oppose Autism Speaks –and there is a massive global movement by autistic people and allies to stop Autism Speaks. In fact, regardless of the many differences among autistic advocates about politics and advocacy, there is one view we pretty much ALL agree on: that Autism Speaks is a hate group. Some reasons: Autism Speaks has allocated hundreds of millions of dollars towards “eugenics” projects that may seek to prevent autistic people from being born. • Autism Speaks is a co-founder of the MSSNG project, a massive, far-reaching project to make a global database of 10,000+ autistic children’s DNA available for use by researchers throughout the world who can fill out a pop-up menu on their website to access it. • The DNA is extracted without the children’s permission. • It is done with the purpose of identifying “autism genes” that will then be used in prenatal testing. • If common genes are identified through this research, people will do prenatal testing and terminate pregnancies if they think there are “signs of autism”. • This project is active in Canada. Autism Speaks Canada has earmarked hundreds of thousands of dollars to its own arm of the project. A group of geneticists in Toronto has also been involved in collecting data for the database. • One of the project’s co-founders, Dr. James Watson, was fired from Cold Spring Harbour Laboratory for his racist remarks about African Americans, intelligence and using eugenics to find “a cure for stupid”.
    [Show full text]
  • Disability in an Age of Environmental Risk by Sarah Gibbons a Thesis
    Disablement, Diversity, Deviation: Disability in an Age of Environmental Risk by Sarah Gibbons A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in English Waterloo, Ontario, Canada, 2016 © Sarah Gibbons 2016 I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract This dissertation brings disability studies and postcolonial studies into dialogue with discourse surrounding risk in the environmental humanities. The central question that it investigates is how critics can reframe and reinterpret existing threat registers to accept and celebrate disability and embodied difference without passively accepting the social policies that produce disabling conditions. It examines the literary and rhetorical strategies of contemporary cultural works that one, promote a disability politics that aims for greater recognition of how our environmental surroundings affect human health and ability, but also two, put forward a disability politics that objects to devaluing disabled bodies by stigmatizing them as unnatural. Some of the major works under discussion in this dissertation include Marie Clements’s Burning Vision (2003), Indra Sinha’s Animal’s People (2007), Gerardine Wurzburg’s Wretches & Jabberers (2010) and Corinne Duyvis’s On the Edge of Gone (2016). The first section of this dissertation focuses on disability, illness, industry, and environmental health to consider how critics can discuss disability and environmental health in conjunction without returning to a medical model in which the term ‘disability’ often designates how closely bodies visibly conform or deviate from definitions of the normal body.
    [Show full text]
  • Constructing Narratives and Identities in Auto/Biography About Autism
    RELATIONAL REPRESENTATION: CONSTRUCTING NARRATIVES AND IDENTITIES IN AUTO/BIOGRAPHY ABOUT AUTISM by MONICA L. ORLANDO Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of English CASE WESTERN RESERVE UNIVERSITY May 2015 2 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of Monica Orlando candidate for the degree of Doctor of Philosophy.* Committee Chair Kimberly Emmons Committee Member Michael Clune Committee Member William Siebenschuh Committee Member Jonathan Sadowsky Committee Member Joseph Valente Date of Defense March 3, 2015 * We also certify that written approval has been obtained for any proprietary material contained therein. 3 Dedications and Thanks To my husband Joe, for his patience and support throughout this graduate school journey. To my family, especially my father, who is not here to see me finish, but has always been so proud of me. To Kim Emmons, my dissertation advisor and mentor, who has been a true joy to work with over the past several years. I am very fortunate to have been guided through this project by such a supportive and encouraging person. To the graduate students and faculty of the English department, who have made my experience at Case both educational and enjoyable. I am grateful for having shared the past five years with all of them. 4 Table of Contents Abstract ............................................................................................................................... 5 Chapter 1: Introduction Relationality and the Construction of Identity in Autism Life Writing ........................ 6 Chapter 2 Clara Claiborne Park’s The Siege and Exiting Nirvana: Shifting Conceptions of Autism and Authority ................................................................................................. 53 Chapter 3 Transformative Narratives: Double Voicing and Personhood in Collaborative Life Writing about Autism ..............................................................................................
    [Show full text]
  • The Joy of Autism: Part 2
    However, even autistic individuals who are profoundly disabled eventually gain the ability to communicate effectively, and to learn, and to reason about their behaviour and about effective ways to exercise control over their environment, their unique individual aspects of autism that go beyond the physiology of autism and the source of the profound intrinsic disabilities will come to light. These aspects of autism involve how they think, how they feel, how they express their sensory preferences and aesthetic sensibilities, and how they experience the world around them. Those aspects of individuality must be accorded the same degree of respect and the same validity of meaning as they would be in a non autistic individual rather than be written off, as they all too often are, as the meaningless products of a monolithically bad affliction." Based on these extremes -- the disabling factors and atypical individuality, Phil says, they are more so disabling because society devalues the atypical aspects and fails to accommodate the disabling ones. That my friends, is what we are working towards -- a place where the group we seek to "help," we listen to. We do not get offended when we are corrected by the group. We are the parents. We have a duty to listen because one day, our children may be the same people correcting others tomorrow. In closing, about assumptions, I post the article written by Ann MacDonald a few days ago in the Seattle Post Intelligencer: By ANNE MCDONALD GUEST COLUMNIST Three years ago, a 6-year-old Seattle girl called Ashley, who had severe disabilities, was, at her parents' request, given a medical treatment called "growth attenuation" to prevent her growing.
    [Show full text]
  • Neuroanatomy-Of-Autism.Pdf
    Review Neuroanatomy of autism David G. Amaral1, Cynthia Mills Schumann2 and Christine Wu Nordahl1 1 The M.I.N.D. Institute, Department of Psychiatry and Behavioral Sciences, University of California, Davis, 2825 50th Street, Sacramento, CA 95817, USA 2 Department of Neurosciences, University of California, San Diego, 8110 La Jolla Shores Drive, Suite 201, La Jolla, CA 92037, USA Autism spectrum disorder is a heterogeneous, behavio- an autism that is generally indistinguishable from early- rally defined, neurodevelopmental disorder that occurs onset autism [7]. The possibility that there is early-onset in 1 in 150 children. Individuals with autism have deficits versus regressive phenotypes of autism might have import- in social interaction and verbal and nonverbal communi- ant implications for the types and time courses of neuro- cation and have restricted or stereotyped patterns of pathology that one might expect to encounter. behavior. They might also have co-morbid disorders including intellectual impairment, seizures and anxiety. Where might one expect to see neuropathology? Postmortem and structural magnetic resonance imaging In Figure 1, we summarize the major brain regions that studies have highlighted the frontal lobes, amygdala and form the putative neural systems involved in the functions cerebellum as pathological in autism. However, there is that are most impacted by the core features of autism. no clear and consistent pathology that has emerged for Several brain regions have been implicated in social beha- autism. Moreover, recent studies emphasize that the vior through experimental animal studies, lesion studies in time course of brain development rather than the final human patients or functional imaging studies [8].
    [Show full text]
  • IN the UNITED STATES COURT of FEDERAL CLAIMS OFFICE of SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 to Be Published
    IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 To Be Published * * * * * * * * * * * * * * * * * * * * * * * * * * * * COLTEN SNYDER, by and through * KATHRYN SNYDER and JOSEPH SNYDER, * his natural guardians and next friends * Omnibus Autism * Proceeding; * Autism Spectrum Disorder, * Pervasive Developmental * Disorder, Causation, Petitioners, * Measles, MMR, Mercury, * Thimerosal, Waiver v. * Applying Daubert, * Weight of Expert Opinions, SECRETARY OF THE DEPARTMENT * Credibility of Witnesses OF HEALTH AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Christopher W. Wickersham, Sr., Esq., Lloyd Bowers, Esq., and Thomas B. Powers, Esq., for petitioners. Alexis S. Babcock, Esq., Katherine Esposito, Esq., Voris Johnson, Esq., and Vincent Matanoski, Esq., U.S. Department of Justice, Washington, DC, for respondent. DECISION1 Vowell, Special Master: On March 22, 2001, Kathryn and Joseph Snyder [“petitioners”] filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. 1 Vaccine Rule 18(b) provides the parties 14 days to request redaction of any material “(i) which is trade secret or commercial or financial information which is privileged and confidential, or (ii) which are medical files and similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” 42 U.S.C. § 300aa12(d)(4)(B). Petitioners have waived their right to request such redaction. See Petitioners’ Notice to W aive the 14-Day “W aiting” Period as Defined in Vaccine Rule 18(b), filed December 2, 2008. Respondent also waived the right to object to the disclosure of information submitted by respondent. See Respondent’s Consent to Disclosure, filed January 14, 2009. Accordingly, this decision will be publicly available immediately after it is filed.
    [Show full text]